drugset / Trial / NCT00191256

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

NCT00191256 ↗

Phase 2 Completed 77 enrolled Eli Lilly and Company
RandomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.

Timeline

Start
2001-06
Primary completion
—
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Gemcitabine Small molecule — —
Subject Paclitaxel Small molecule — —